Pharmacy Times November 30, 2024
Key Takeaways
- Global disparities in cancer drug costs and availability are significant, with low-income countries disproportionately affected.
- Rising cancer cases and mortality rates are projected, especially in low-income regions, due to barriers like high costs and inadequate infrastructure.
- Proposed solutions include sharing production secrets, price discrimination, and international funding to improve access to cancer treatments.
- Emphasizing prevention, screening, and treatment as global priorities is crucial to address inequities in cancer care access.
Potential solutions can include international funding, improved primary health care measures, and cost-effective screening methods.
According to a recent analysis published in Cancer, there are evident disparities in the cost and availability of cancer drugs across different regions of the globe. Significant gaps are present between...
Today's Sponsors
Today's Sponsor